This week on the Podcast Dr. Jack Cush reviews the news and journal articles, including the risks of dying, developing RA or autoimmune disease!
Dr. John Cush RheumNow
3 years 5 months ago
May 16th--Tuesday Night Rheumatology: POD 3: Vasculitis: Evolution and Advances
This webinar will feature highlights from these lectures followed by live audience Q & A:
-New Therapies for PMR & GCA
-Assessment of GCA and PMR
-GPA Treatment Choices
https://t.co/fphj3seU3K https://t.co/GSL41UZZ2Y
Dr. John Cush RheumNow
3 years 5 months ago
Pregnancy in PsA
RheumNow Live 2023: Christina Chambers, PhD, MPH, University of California, San Diego School of Medicine
https://t.co/ImgAwCvawE https://t.co/9GCZ1tBmkV
Dr. John Cush RheumNow
3 years 5 months ago
Study of 6039 NHL hockey players showed mortality rates were similar between fighters & controls (3.9% v4.2%) & Penalized vs not (7.1.% v 5.5%). Yet controls lived (~56yrs) avg of 10 yrs longer than fighters/penalized (~46yrs) w/ more suicide & overdose https://t.co/EKOeEKSejN https://t.co/7Axpz0QibY
Opportunistic and chronic infections may be rare and are often difficult to diagnose, especially in patients with autoimmune inflammatory rheumatic diseases (AIIRD), that may be immunocompromised. A EULAR task force has established recommendations for screening and prophylaxis against OI.
Dr. John Cush RheumNow
3 years 5 months ago
JAK inhibitors in Psoriasis and PsA
RheumNow Live 2023: Eric Ruderman, MD, Northwestern University, Feinberg School of Medicine
https://t.co/OV4rRR6eCh https://t.co/uY9MnwGveV
Dr. John Cush RheumNow
3 years 5 months ago
B-Cell Stimulating Factors Tied to Lymphoma in Sjogren's
Genetic blood tests indicated that BTK and a cytokine called APRIL were overexpressed in patients with primary Sjögren's syndrome who subsequently developed lymphoma, French researchers reported.
https://t.co/SPmdBJ8IFh https://t.co/ad2j6XaSkK
Dr. John Cush RheumNow
3 years 5 months ago
Did you miss Tuesday Night Rheumatology this week?
This webinar features highlights from:
Preclinical RA – To Treat or Not To Treat
Year of the JAKi
Fibroblast/Stromal Cells
https://t.co/yVQLtG6fEe https://t.co/WMXcKdqwdP
A cohort study analyzed the risk of venous thromboembolism (VTE) in dermatomyositis (DM) patients treated with intravenous immunoglobulin (IVIG).
Dr. John Cush RheumNow
3 years 5 months ago
Another NHANES survey of US adults shows increased prevalence of RA for those exposed to high levels of polycyclic aromatic hydrocarbons (PAH)(OR: 1.8; p=0.02). 90% of the smoking effect on RA risk is mediated by PAH https://t.co/N93MbKspRM https://t.co/uqH75vOZrA
Dr. John Cush RheumNow
3 years 5 months ago
Have a Rheumatology question or case for Jack Cush? Record it here and we'll feature it on an upcoming podcast. Tell us your name and where you practice rheumatology.
https://t.co/0mC7PxF0DU https://t.co/klbnwjcPbM
Dr. John Cush RheumNow
3 years 5 months ago
Study of 481 incident RA:
- no risk of RA w/ tea, alcohol & sugar-soft drinks
- Incr RA risk seen w/ coffee [≥4 vs ≤1cup, HR=1.24;p=0.04] & diet drinks [HR=1.66;never-smokers]
- Reduced RA risk w/ mod EtOH (ever-smokers;HR=0.63) & wine (seropos RA) https://t.co/gPZkTl9rid https://t.co/khYEZYFotl
